Virbac

From DolceraWiki
Jump to: navigation, search

Go back to homepage


Virbac
Financial Details
Total Company Revenue in 2010 $ 0.781 Bn
Revenue from Animal Health Market in 2010 $ 0.781 Bn
% of revenue from Animal Health in 2010 100% (The company is only into Animal Health)
Segmentwise Revenue Breakup ($ Bn)
Livestock Vaccines 0.294
Companion Vaccines 0.469
Number of Major Vaccines (Animal-wise)
Poultry 0
Swine 0
Fish 0
Sheep 0
Cattle 0
Canine 6
Feline 2
Equine 0
Mergers and Acquisitions (2009 - 2011) Consideration
Santa Elena laboratory $ 3.7 Mn
Veterinary Assets from Pfizer Inc. undisclosed
Future Focus Areas
Veterinary Vaccines under trial 0
Future Focus Areas of the company in the Veterinary Vaccines Market Bacterian and virus vaccines
Parasiticides and vaccines for cattle and sheep




Go back to homepage